{"paper_id":"01b01147-f1ec-4181-82e8-39bf227eb0ec","body_text":"The Effect of Ulipristal Acetate on Surgical Endometriosis Created in Rats\nAbstract\nKeywords\nReferences\n- Giudice LC, Kao LC. Endometriosis. The Lancet. 2004;364(9447):1789-1799.\n- Bulun SE, Yilmaz BD, Sison C, et al. Endometriosis. Endocrine Reviews. 2019;40(4):1048-1079.\n- Meuleman C, Vandenabeele B, Fieuws S, Spiessens C, Timmerman D, D’Hooghe T. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertility and Sterility. 2009;92(1):68-74.\n- Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstetrics and Gynecology Clinics of North America. 1997;24(2):235-258.\n- Chaichian S. It is the time to treat endometriosis based on pathophysiology. Journal of Reproduction & Infertility. 2019;20(1):1-2.\n- Ferrero S, Barra F, Leone Roberti Maggiore U. Current and emerging therapeutics for the management of endometriosis. Drugs. 2018;78(10):995-1012.\n- Chwalisz K, Garg R, Brenner RM, Schubert G, Elger W. Selective progesterone receptor modulators (SPRMs): a novel therapeutic concept in endometriosis. Annals of the New York Academy of Sciences. 2002;955:373-393,396-406.\n- Huniadi CA, Pop OL, Antal TA, Stamatian F. The effects of ulipristal on Bax/Bcl-2, cytochrome C, Ki-67 and cyclooxygenase-2 expression in a rat model with surgically induced endometriosis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2013;169(2):360-365.\nDetails\nPrimary Language\nEnglish\nSubjects\nObstetrics and Gynaecology\nJournal Section\nResearch Article\nAuthors\nHacı Öztürk Şahin\n0000-0002-7915-8235\nTürkiye\nNihal Kılınç\n0000-0002-9731-0560\nTürkiye\nBülent Demir\n0000-0001-6608-9886\nTürkiye\nPublication Date\nDecember 22, 2022\nSubmission Date\nSeptember 26, 2022\nAcceptance Date\nOctober 17, 2022\nPublished in Issue\nYear 2022 Volume: 2 Number: 3","source_license":"CC0","license_restricted":false}